Overview

Benzydamine Oromucosal Solution in Oral Mucositis (BOOM)

Status:
Not yet recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
The aim of the present study is to collect data on the feasibility of a preventative/therapeutic approach of radiation-induced oral mucositis with benzydamine oromucosal solution (mouthwash) in patients with head and neck cancer.
Phase:
Phase 4
Details
Lead Sponsor:
Aziende Chimiche Riunite Angelini Francesco S.p.A
Collaborator:
PPD
Treatments:
Benzydamine